Related Experiment Videos

Chromosome 11 loss from thymic lymphomas induced in heterozygous Trp53 mice by phenolphthalein

J E Hulla1, J E French, J K Dunnick

  • 1University of North Dakota School of Medicine, Grand Forks, ND, USA. hulla@niehs.nih.gov

Insights

This study used p53-deficient mice to investigate carcinogenesis mechanisms. Phenolphthalein exposure revealed significant loss of heterozygosity on chromosome 11, suggesting a role for p53 in suppressing mitotic recombination.

Area of Science:

  • Genetics
  • Molecular Biology
  • Toxicology

Background:

  • The tumor suppressor gene p53 plays a critical role in maintaining genomic stability.
  • p53 haploinsufficiency can impair its tumor-suppressive functions.
  • Understanding carcinogenesis mechanisms is crucial for identifying human carcinogens.

Purpose of the Study:

  • To investigate the role of p53 in carcinogenesis using a mouse model.
  • To evaluate the utility of p53-deficient mice for carcinogen identification.
  • To elucidate the mechanisms underlying phenolphthalein-induced tumorigenesis.

Main Methods:

  • C57BL/6 mice heterozygous for a null p53 allele (p53 (+/-)) were administered phenolphthalein.
  • DNA from induced thymic lymphomas was analyzed for loss of heterozygosity (LOH) at the Trp53 locus and other polymorphic loci.
  • Allelotyping was performed at approximately five centiMorgan intervals across chromosome 11.

Main Results:

  • Phenolphthalein induced thymic lymphomas in p53 (+/-) mice.
  • Significant LOH was observed on chromosome 11 in all 28 informative loci examined.
  • Allelic patterns indicated mitotic homologous recombination during embryogenesis.
  • Mitotic recombination was linked to p53 haploinsufficiency.

Conclusions:

  • p53 haploinsufficiency may lead to increased mitotic recombination.
  • The p53-deficient mouse model is valuable for studying carcinogenesis.
  • Phenolphthalein's carcinogenic mechanism involves alterations on chromosome 11.

Related Concept Videos